SPIA
GHDX

Steward Partners Investment Advisory’s Genomic Health, Inc. GHDX Stock Holding History

Steward Partners Investment Advisory’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-500
Closed -$15K – 2603
2018
Q1 		$15K Hold
500
– – ﹤0.01% 1454
2017
Q4 		$17K Buy
+500
New +$15.9K ﹤0.01% 1197

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Steward Partners Investment Advisory's GHDX Position: Q2 2018 in Review

Steward Partners Investment Advisory sold out of Genomic Health, Inc. (GHDX) in Q2 2018, closing a stake of 500 shares — an estimated $15K sold.

Steward Partners Investment Advisory first reported a position in GHDX in Q4 2017 and held it in 2 quarters. The position peaked at $17K in Q4 2017. 166 funds tracked by Wall St. Rank hold GHDX as of Q2 2018.

  • Steward Partners Investment Advisory reported no remaining Genomic Health, Inc. position as of Q2 2018 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 500 Genomic Health, Inc. shares in Q2 2018, an estimated $15K.
  • Steward Partners Investment Advisory first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Genomic Health, Inc. position peaked at $17K in Q4 2017.
  • 166 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2018, filed 20 Jul 2018.